← back to search

Neil K. Aaronson

Amsterdam University of the Arts · NL
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer survivorship and care, Cancer-related cognitive impairment studies, Health Systems, Economic Evaluations, Quality of Life, and Childhood Cancer Survivors' Quality of Life.
h-index
125
citations
66,849
works
653
NIH funding
primary concept
email

Recent publications

Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis.
2026cited by 0position: contributordoi
Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategy
European Journal of Cancer 2025cited by 11position: middledoi
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial
Journal of Clinical Oncology 2025cited by 7position: middledoi
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial.
2025cited by 6position: contributordoi
Impact of exercise on sexual health, body image, and therapy‐related symptoms in women with metastatic breast cancer: The randomized controlled <scp>PREFERABLE</scp>‐<scp>EFFECT</scp> trial
International Journal of Cancer 2025cited by 5position: middledoi
Exercise effects on symptoms of depression and anxiety vary by patient, clinical, and intervention characteristics in cancer survivors: Results from pooled analyses of individual participant data of 26 RCTs
Supportive Care in Cancer 2025cited by 4position: middledoi
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial
Nature Medicine 2024cited by 59position: middledoi
Dropout from exercise trials among cancer survivors—An individual patient data meta‐analysis from the <scp>POLARIS</scp> study
Scandinavian Journal of Medicine and Science in Sports 2024cited by 9position: middledoi
Metastatic breast cancer patients’ preferences for exercise programs: a latent class analysis using data from a survey in five European countries
Supportive Care in Cancer 2024cited by 4position: middledoi
Cost-utility analysis of a supervised exercise program for patients with metastatic breast cancer in the PREFERABLE-EFFECT randomized controlled trial (RCT).
Journal of Clinical Oncology 2024cited by 3position: middledoi
Abstract GS02-10: Effects of a structured and individualized exercise program on fatigue and health-related quality of life in patients with metastatic breast cancer: the multinational randomized controlled PREFERABLE-EFFECT study
Cancer Research 2024cited by 2position: middledoi
Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study
Quality of Life Research 2023cited by 46position: middledoi
PERSPECTIVEs on supervised exercise programs in people with metastatic breast cancer- a qualitative study in four European countries
Supportive Care in Cancer 2023cited by 19position: middledoi
Perspectives of patients with metastatic breast cancer on physical exercise programs: results from a survey in five European countries
Supportive Care in Cancer 2023cited by 16position: middledoi
Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
2023cited by 15position: contributordoi
PERSPECTIVEs on supervised exercise programs in people with metastatic breast cancer- a qualitative study in four European countries.
2023cited by 14position: contributordoi
Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial.
2023cited by 13position: contributordoi
Perspectives of patients with metastatic breast cancer on physical exercise programs: results from a survey in five European countries.
2023cited by 12position: contributordoi
Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis
Journal of Cancer Survivorship 2023cited by 8position: middledoi
Dutch prostate cancer patients' views about exercise and experience with exercise advice: a national survey
Journal of Cancer Survivorship 2023cited by 2position: middledoi
Translating Evidence from Dutch Exercise Oncology Trials in Patients with Breast Cancer into Clinical Practice Using the RE‐AIM Framework
European Journal of Cancer Care 2023cited by 1position: contributordoi
Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP.
2023cited by 0position: contributordoi
Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer
European Journal of Cancer 2022cited by 151position: middledoi
Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire
Journal of Cancer Survivorship 2022cited by 36position: middledoi
Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life: the EFFECT study
Trials 2022cited by 36position: middledoi
Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors
JACC CardioOncology 2022cited by 29position: middledoi
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
Neuro-Oncology 2022cited by 18position: middledoi
Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
2022cited by 5position: contributordoi
Specialist versus Primary Care Prostate Cancer Follow-Up: A Process Evaluation of a Randomized Controlled Trial.
2022cited by 3position: contributordoi
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
The Lancet Oncology 2021cited by 92position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 22 papers (2019–2026)Martijn M. Stuiver · Utrecht University10 papers (2014–2024)Anne M. May · Utrecht University8 papers (2021–2024)Yvonne Wengström · Karolinska University Hospital7 papers (2022–2024)Karen Steindorf · Charité - Universitätsmedizin Berlin6 papers (2022–2024)Mogens Grøenvold · University of Copenhagen6 papers (2013–2025)Martijn M. Stuiver · Cancer Genomics Centre6 papers (2020–2025)Michael Weller · Center for Neurosciences6 papers (2019–2026)Corneel Coens · KU Leuven6 papers (2019–2025) · 6 papers (2014–2020)Morten Aagaard Petersen · University of California, Berkeley6 papers (2013–2025)Wolfgang Wick · Heidelberger Institut für Radioonkologie6 papers (2019–2026)Andrew Bottomley · European Organisation for Research and Treatment of Cancer5 papers (2019–2022)Anne M. May · Nationwide Children's Hospital5 papers (2021–2025) · 5 papers (2013–2025)Martin J. van den Bent · St James's University Hospital5 papers (2019–2022)Jaap C. Reijneveld · Academic Medical Center5 papers (2019–2025)Anna Costantini · University of Southampton5 papers (2013–2020)Johanna Depenbusch · Heidelberg University5 papers (2022–2024)Roger Stupp · Northwestern University5 papers (2019–2026)